REFERENCIAS

  1. National Institute for Health and Clinical Excellence: Guidance. Headaches: Diagnosis and Management of Headaches in Young People and Adults. Editors National Clinical Guideline Centre (UK). Source London: Royal College of Physicians (UK); 2012.
    Ver documentación

  2. Ashkenazi A1, Silberstein SD. Headache management for the pain specialist Reg Anesth Pain Med. 2004;29(5):462-75.
    Ver documentación

  3. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Prognosis of migraine and tension-type headache: a population-based follow-up study. Neurology. 2005 Aug 23;65(4):580-5.
    Ver documentación

  4. Guy Stephens, Sheena Derry, R Andrew Moore. Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults. Cochrane Pain, Palliative and Supportive Care Group. Cochrane Database of Systematic Reviews. 2016.
    Ver documentación

  5. Graham GG1, Davies MJ, Day RO, Mohamudally A, Scott KF. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201-32.
    Ver documentación

  6. Paracetamol –Monografía -Equipo de redacción de IQB (Centro colaborador de La Administración Nacional de Medicamentos, alimentos y Tecnología Médica - ANMAT - Argentina). Rv 04-2014.

  7. Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med. 2000;160(22):3486-92.
    Ver documentación

  8. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev. 2013;(4):CD008040.
    Ver documentación

  9. Headache. Practice Guideline. American Academy of Neurology. Rv.2016.
    Ver documentación

Redes Sociales